Flindokalner - Bristol-Myers Squibb
Alternative Names: BMS 204352; MaxiPost™Latest Information Update: 20 Mar 2003
At a glance
- Originator Bristol-Myers Squibb
- Class Neuroprotectants; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stroke